A 60-year-old woman with type 2 diabetes, BMI 30 kg/m² and a prior non-ST elevation myocardial infarction is taking maximally tolerated metformin. Her...

Question

A 60-year-old woman with type 2 diabetes, BMI 30 kg/m² and a prior non-ST elevation myocardial infarction is taking maximally tolerated metformin. Her HbA1c is 8.1% (65 mmol/mol) despite lifestyle measures. According to contemporary Australian recommendations, which additional agent would be most appropriate to add?

Accepted Answer

SGLT2 inhibitor (e.g. empagliflozin)

Answer

Sulfonylurea (e.g. gliclazide)

Answer

Basal insulin

Answer

DPP-4 inhibitor

Answer

Alpha-glucosidase inhibitor

au-racp MCQ (SBA): Type 2 diabetes with cardiovascular disease